• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

描述性流行病学表明“我们所有人”数据库是罕见病和未确诊疾病群体的通用资源。

Descriptive epidemiology demonstrating the All of Us database as a versatile resource for the rare and undiagnosed disease community.

作者信息

Magee Drenen J, Kicker Sierra, Thomas Aeisha

机构信息

Department of Biological and Health Sciences, Crown College, St Bonifacius, MN 55375, United States.

出版信息

J Am Med Inform Assoc. 2025 Mar 1;32(3):579-585. doi: 10.1093/jamia/ocae241.

DOI:10.1093/jamia/ocae241
PMID:39715481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11833481/
Abstract

OBJECTIVE

We aim to demonstrate the versatility of the All of Us database as an important source of rare and undiagnosed disease (RUD) data, because of its large size and range of data types.

MATERIALS AND METHODS

We searched the public data browser, electronic health record (EHR), and several surveys to investigate the prevalence, mental health, healthcare access, and other data of select RUDs.

RESULTS

Several RUDs have participants in All of Us [eg, 75 of 100 rare infectious diseases (RIDs)]. We generated health-related data for undiagnosed, sickle cell disease (SCD), cystic fibrosis (CF), and infectious (2 diseases) and chronic (4 diseases) disease pools.

CONCLUSION

Our results highlight the potential value of All of Us with both data breadth and depth to help identify possible solutions for shared and disease-specific biomedical and other problems such as healthcare access, thus enhancing diagnosis, treatment, prevention, and support for the RUD community.

摘要

目的

我们旨在证明“我们所有人”数据库作为罕见和未确诊疾病(RUD)数据的重要来源的多功能性,因为其规模庞大且数据类型多样。

材料与方法

我们搜索了公共数据浏览器、电子健康记录(EHR)以及多项调查,以调查特定RUD的患病率、心理健康、医疗服务可及性及其他数据。

结果

有几种RUD在“我们所有人”中有参与者[例如,100种罕见传染病(RID)中有75种]。我们为未确诊疾病、镰状细胞病(SCD)、囊性纤维化(CF)以及传染病(2种疾病)和慢性病(4种疾病)池生成了与健康相关的数据。

结论

我们的结果凸显了“我们所有人”数据库在数据广度和深度方面的潜在价值,有助于确定针对共同的和特定疾病的生物医学及其他问题(如医疗服务可及性)的可能解决方案,从而加强对RUD群体的诊断、治疗、预防和支持。

相似文献

1
Descriptive epidemiology demonstrating the All of Us database as a versatile resource for the rare and undiagnosed disease community.描述性流行病学表明“我们所有人”数据库是罕见病和未确诊疾病群体的通用资源。
J Am Med Inform Assoc. 2025 Mar 1;32(3):579-585. doi: 10.1093/jamia/ocae241.
2
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.地中海贫血、镰状细胞病、囊性纤维化和泰萨二氏病的孕前风险评估。
Cochrane Database Syst Rev. 2021 Oct 11;10(10):CD010849. doi: 10.1002/14651858.CD010849.pub4.
3
Folate supplementation in people with sickle cell disease.镰状细胞病患者的叶酸补充
Cochrane Database Syst Rev. 2018 Mar 16;3(3):CD011130. doi: 10.1002/14651858.CD011130.pub3.
4
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2023 Aug 4;8(8):CD012380. doi: 10.1002/14651858.CD012380.pub3.
5
Hydroxyurea (hydroxycarbamide) for sickle cell disease.羟基脲(羟脲)治疗镰状细胞病。
Cochrane Database Syst Rev. 2022 Sep 1;9(9):CD002202. doi: 10.1002/14651858.CD002202.pub3.
6
Interventions for improving adherence to airway clearance treatment and exercise in people with cystic fibrosis.改善囊性纤维化患者气道清除治疗和运动依从性的干预措施。
Cochrane Database Syst Rev. 2023 Jul 18;7(7):CD013610. doi: 10.1002/14651858.CD013610.pub2.
7
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2017 Jul 3;7(7):CD012380. doi: 10.1002/14651858.CD012380.pub2.
8
Laser therapy for retinopathy in sickle cell disease.激光疗法治疗镰状细胞病视网膜病变。
Cochrane Database Syst Rev. 2022 Dec 12;12(12):CD010790. doi: 10.1002/14651858.CD010790.pub3.
9
Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia.改善镰状细胞病或地中海贫血患者铁螯合疗法依从性的干预措施。
Cochrane Database Syst Rev. 2018 May 8;5(5):CD012349. doi: 10.1002/14651858.CD012349.pub2.
10
Inhaled nitric oxide for treating pain crises in people with sickle cell disease.吸入一氧化氮治疗镰状细胞病患者的疼痛危象。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD011808. doi: 10.1002/14651858.CD011808.pub3.

引用本文的文献

1
Returning value to communities from the All of Us Research Program through innovative approaches for data use, analysis, dissemination, and research capacity building.通过创新的数据使用、分析、传播和研究能力建设方法,将价值回馈给“我们所有人”研究计划中的各个社区。
J Am Med Inform Assoc. 2024 Dec 1;31(12):2773-2780. doi: 10.1093/jamia/ocae276.

本文引用的文献

1
Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer's disease with real-world clinical validation.利用生成式人工智能对阿尔茨海默病药物再利用候选药物进行优先级排序,并进行真实世界临床验证。
NPJ Digit Med. 2024 Feb 26;7(1):46. doi: 10.1038/s41746-024-01038-3.
2
Genomic data in the All of Us Research Program.全美国研究计划中的基因组数据。
Nature. 2024 Mar;627(8003):340-346. doi: 10.1038/s41586-023-06957-x. Epub 2024 Feb 19.
3
Comparison of phenomic profiles in the All of Us Research Program against the US general population and the UK Biobank.比较“All of Us 研究计划”中的表型谱与美国普通人群和英国生物库。
J Am Med Inform Assoc. 2024 Apr 3;31(4):846-854. doi: 10.1093/jamia/ocad260.
4
Enhancing study designs of disease prevalence investigations conducted with the All of Us Research Program.加强通过“我们所有人”研究计划开展的疾病患病率调查的研究设计。
J Am Acad Dermatol. 2024 May;90(5):e181-e182. doi: 10.1016/j.jaad.2023.12.059. Epub 2024 Jan 17.
5
Prioritization of research engaged with rare disease stakeholders: a systematic review and thematic analysis.优先考虑与罕见病利益相关者合作的研究:系统评价和主题分析。
Orphanet J Rare Dis. 2023 Nov 23;18(1):363. doi: 10.1186/s13023-023-02892-2.
6
Prevalence of calcinosis cutis in the United States using the All of Us research database.利用“我们所有人”研究数据库评估美国皮肤钙质沉着症的患病率。
J Am Acad Dermatol. 2024 Feb;90(2):405-406. doi: 10.1016/j.jaad.2023.09.076. Epub 2023 Oct 8.
7
A qualitative evaluation of patient and parent experiences with an undiagnosed diseases program.对一个未确诊疾病项目的患者和家长体验的定性评估。
Am J Med Genet A. 2024 Feb;194(2):131-140. doi: 10.1002/ajmg.a.63417. Epub 2023 Sep 26.
8
Cystic fibrosis-related mortality in the United States from 1999 to 2020: an observational analysis of time trends and disparities.1999 年至 2020 年美国囊性纤维化相关死亡率:时间趋势和差异的观察性分析。
Sci Rep. 2023 Sep 12;13(1):15030. doi: 10.1038/s41598-023-41868-x.
9
Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD).在三级保健系统中实施罕见病的基因组医学:梅奥诊所罕见和未确诊疾病计划(PRaUD)。
J Transl Med. 2023 Jun 23;21(1):410. doi: 10.1186/s12967-023-04183-7.
10
Correction: Precision information extraction for rare disease epidemiology at scale.更正:大规模罕见病流行病学的精准信息提取。
J Transl Med. 2023 Apr 29;21(1):291. doi: 10.1186/s12967-023-04127-1.